US Patent 11634422 Inhibitors of activin receptor-like kinase
Patent 11634422 was granted and assigned to Blueprint Medicines on April, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 29, 2020
0
Date of Patent
April 25, 2023
0
Patent Applicant
Patent Application Number
16887262
0
Patent Citations
Patent Inventor Names
Brett D. Williams
0
Paul E. Fleming
0
Natasja Brooijmans
0
Mark Cronin
0
Kevin J. Wilson
0
Joseph L. Kim
0
Jason D. Brubaker
0
Douglas Wilson
0
Brian Lewis Hodous
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11634422 Inhibitors of activin receptor-like kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
